NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Ori Biotech

Ori Biotech

Private
LondonHealthcare & Life Scienceshttps://oribiotech.com/

Last Round

Series B

Jan 18, 2022

Total Funding Raised

$139.4M

Company Overview

Ori Biotech is a biotechnology company that specializes in automated manufacturing technology for cell and gene therapies, enhancing process efficiency and scalability for therapeutic developers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Smart Manufacturing, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

cell therapy manufacturinggene therapy manufacturingautologous cell therapyautomated manufacturing platformbioprocessing automationclosed-system manufacturingbiotech manufacturingadvanced manufacturing technologyAMTCAR-T cell productionbioreactorprocess automationlab automationbiotech hardwarecell therapy scale-up

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ori Biotech Comparables

Compare Ori Biotech with similar companies based on industry and business-model similarity.

Ori Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Adva Biotechnology
90%
Cellular Origins
88%
Cellares
87%

Ori Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJan 18, 2022
Series AOct 14, 2020
SeedJan 8, 2020

Key People

Founding team and executive leadership

Jason C. Foster

Chief Executive Officer And Executive Director

Executive Team

Stuart Milne

Chief Technology Officer

Executive Team

MSc Leonor Monteiro

Group SVP Finance CFO

Executive Team

Ori Biotech Investors

Notable investors and investment history

Ori Biotech investors
InvestorRounds
Amadeus Capital PartnersSeries B, Series A, Seed
Northpond VenturesSeries B, Series A
Chimera Investment LLCSeries B
Kindred CapitalSeed, Series A
Novalis LifeSciencesSeries B
Puhua CapitalSeries B
Northpond VenturesSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 2, 2025

    Sponsored session on commercial viability for cell and gene therapies.

  • Mar 18, 2025

    Preferred Partner Network aims to accelerate cell and gene therapy development.

Ori Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ori Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ori Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range79
Year Founded2015
Last FundingJan 18, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.